These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 37331680

  • 1. Metabolic rewiring and epigenetic reprogramming in leptin receptor-deficient db/db diabetic nephropathy mice.
    Sarwar MS, Cheng D, Peter RM, Shannar A, Chou P, Wang L, Wu R, Sargsyan D, Goedken M, Wang Y, Su X, Hart RP, Kong AN.
    Eur J Pharmacol; 2023 Aug 15; 953():175866. PubMed ID: 37331680
    [Abstract] [Full Text] [Related]

  • 2. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
    Li S, Wu R, Wang L, Dina Kuo HC, Sargsyan D, Zheng X, Wang Y, Su X, Kong AN.
    Mol Carcinog; 2022 Jan 15; 61(1):111-121. PubMed ID: 34727410
    [Abstract] [Full Text] [Related]

  • 3. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
    Wen L, Zhang Z, Peng R, Zhang L, Liu H, Peng H, Sun Y.
    J Cell Biochem; 2019 Oct 15; 120(10):17520-17533. PubMed ID: 31106482
    [Abstract] [Full Text] [Related]

  • 4. Effect of TET2 on the pathogenesis of diabetic nephropathy through activation of transforming growth factor β1 expression via DNA demethylation.
    Yang L, Zhang Q, Wu Q, Wei Y, Yu J, Mu J, Zhang J, Zeng W, Feng B.
    Life Sci; 2018 Aug 15; 207():127-137. PubMed ID: 29705354
    [Abstract] [Full Text] [Related]

  • 5. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y, Liu Y, Lai Z, Huang J, Li C, Zhang Y, Gong X, Deng J, Ye X, Li X.
    J Ethnopharmacol; 2021 Apr 24; 270():113806. PubMed ID: 33444721
    [Abstract] [Full Text] [Related]

  • 6. DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA.
    Li W, Sargsyan D, Wu R, Li S, Wang L, Cheng D, Kong AN.
    Chem Res Toxicol; 2019 Oct 21; 32(10):1977-1988. PubMed ID: 31525975
    [Abstract] [Full Text] [Related]

  • 7. Epigenetics in the pathogenesis of diabetic nephropathy.
    Li X, Lu L, Hou W, Huang T, Chen X, Qi J, Zhao Y, Zhu M.
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan 25; 54(2):163-172. PubMed ID: 35130617
    [Abstract] [Full Text] [Related]

  • 8. Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells.
    Chou PJ, Sarwar MS, Wang L, Wu R, Li S, Hudlikar RR, Wang Y, Su X, Kong AN.
    Cancer Prev Res (Phila); 2023 Jun 01; 16(6):321-332. PubMed ID: 36867722
    [Abstract] [Full Text] [Related]

  • 9. Epigenomic, Transcriptomic, and Protective Effect of Carotenoid Fucoxanthin in High Glucose-Induced Oxidative Stress in Mes13 Kidney Mesangial Cells.
    Hudlikar RR, Sargsyan D, Li W, Wu R, Zheng M, Kong AN.
    Chem Res Toxicol; 2021 Mar 15; 34(3):713-722. PubMed ID: 33448797
    [Abstract] [Full Text] [Related]

  • 10. Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice.
    Qiu Y, Kang N, Wang X, Yao Y, Cui J, Zhang X, Zheng L.
    PeerJ; 2023 Mar 15; 11():e16155. PubMed ID: 37790634
    [Abstract] [Full Text] [Related]

  • 11. GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb/db mice.
    Meng Q, Tian X, Li J, Pruekprasert N, Dhawan R, Holz GG, Cooney RN.
    Sci Rep; 2022 Dec 26; 12(1):22360. PubMed ID: 36572735
    [Abstract] [Full Text] [Related]

  • 12. Epigenome and transcriptome study of moringa isothiocyanate in mouse kidney mesangial cells induced by high glucose, a potential model for diabetic-induced nephropathy.
    Li S, Li W, Wu R, Yin R, Sargsyan D, Raskin I, Kong AN.
    AAPS J; 2019 Dec 05; 22(1):8. PubMed ID: 31807911
    [Abstract] [Full Text] [Related]

  • 13. Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice.
    Sembach FE, Fink LN, Johansen T, Boland BB, Secher T, Thrane ST, Nielsen JC, Fosgerau K, Vrang N, Jelsing J, Pedersen TX, Østergaard MV.
    Physiol Rep; 2019 Dec 05; 7(24):e14333. PubMed ID: 31876119
    [Abstract] [Full Text] [Related]

  • 14. Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.
    Wang L, Shannar AAF, Wu R, Chou P, Sarwar MS, Kuo HC, Peter RM, Wang Y, Su X, Kong AN.
    Mol Nutr Food Res; 2022 Jun 05; 66(12):e2200028. PubMed ID: 35429118
    [Abstract] [Full Text] [Related]

  • 15. Renal transcriptome analysis of uninephrectomized db/db mice identified a mechanism for the transition to severe diabetic nephropathy.
    Maekawa M, Maekawa T, Sasase T, Wakashima T, Uemura A, Uno K, Ohta T, Yamada T.
    Exp Anim; 2024 Feb 14; 73(1):29-40. PubMed ID: 37482420
    [Abstract] [Full Text] [Related]

  • 16. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
    Wang Q, Ren D, Li Y, Xu G.
    Cell Cycle; 2019 Feb 14; 18(6-7):696-707. PubMed ID: 30784349
    [Abstract] [Full Text] [Related]

  • 17. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.
    Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K, Natarajan R.
    Kidney Int; 2014 Feb 14; 85(2):362-73. PubMed ID: 24088954
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA, Tak Park J, Natarajan R.
    Semin Nephrol; 2013 Jul 14; 33(4):341-53. PubMed ID: 24011576
    [Abstract] [Full Text] [Related]

  • 19. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W, Gao S, Zhang Y, Wang M, Liu Y, Li T, Gao C, Zhou Y, Bian B, Wang H, Wei X, Sato T, Si N, Zhao W, Zhao H.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):117073. PubMed ID: 37619856
    [Abstract] [Full Text] [Related]

  • 20. SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.
    Lu YP, Zhang ZY, Wu HW, Fang LJ, Hu B, Tang C, Zhang YQ, Yin L, Tang DE, Zheng ZH, Zhu T, Dai Y.
    J Transl Med; 2022 Sep 14; 20(1):420. PubMed ID: 36104729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.